Marimed (MRMD) Capital Expenditures (2014 - 2026)
Marimed (MRMD) posted quarterly Capital Expenditures of $19000.0 for Q1 2026, down 92.86% year-over-year from $266000.0 in Q1 2025, and down 98.71% quarter-over-quarter from $1.5 million in Q4 2025.
Marimed (MRMD) Capital Expenditures (2014 - 2026) Analysis & Trends
Marimed (MRMD) has reported Capital Expenditures for 13 consecutive years, with $19000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 92.86% year-over-year to $19000.0; the TTM figure through Mar 2026 stood at $4.4 million (up 14.83% YoY), while the FY2025 annual figure was $2.6 million, down 78.21% from the prior year.
- Capital Expenditures declined to $19000.0 in Q1 2026 per MRMD's latest filing, from $1.5 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.4 million in Q4 2023 and bottomed at -$19000.0 in Q1 2023.
- Historically, Capital Expenditures has averaged $1.7 million across 5 years, with a median of $1.3 million in 2022.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 23517.65% — and 2023, when it sank 100.47%.
- Marimed's Capital Expenditures stood at $1.1 million in 2022, then jumped by 389.18% to $5.4 million in 2023, then slumped by 80.34% to $1.1 million in 2024, then jumped by 39.13% to $1.5 million in 2025, then tumbled by 98.71% to $19000.0 in 2026.
- Business Quant data shows MRMD's Capital Expenditures at $19000.0 in Q1 2026, $1.5 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Jun 30, 2026 | 700,000.00 |
| Mar 31, 2026 | 19,000.00 |
| Mar 31, 2026 | 19,000.00 |
| Dec 31, 2025 | 1.47 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 266,000.00 |
| Mar 31, 2025 | 266,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Mar 31, 2024 | 3.37 Mn |